BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Chemical substance: Deferasirox

Presentation	Product	Chemical substance	Chapter	Items dispensed
Deferasirox 360mg tablets 0901030K0AAAFAF	Deferasirox	Deferasirox	Nutrition and Blood	41
Deferasirox 180mg tablets 0901030K0AAAEAE	Deferasirox	Deferasirox	Nutrition and Blood	8
Deferasirox 90mg tablets 0901030K0AAADAD	Deferasirox	Deferasirox	Nutrition and Blood	6
Exjade 360mg tablets 0901030K0BBAFAF	Exjade	Deferasirox	Nutrition and Blood	4
Deferasirox 500mg dispersible tablets sugar free 0901030K0AAACAC	Deferasirox	Deferasirox	Nutrition and Blood	1
Exjade 180mg tablets 0901030K0BBAEAE	Exjade	Deferasirox	Nutrition and Blood	1
Exjade 90mg tablets 0901030K0BBADAD	Exjade	Deferasirox	Nutrition and Blood	1
Deferasirox 125mg dispersible tablets sugar free 0901030K0AAAAAA	Deferasirox	Deferasirox	Nutrition and Blood	No data available
Deferasirox 250mg dispersible tablets sugar free 0901030K0AAABAB	Deferasirox	Deferasirox	Nutrition and Blood	No data available
Exjade 125mg dispersible tablets 0901030K0BBAAAA	Exjade	Deferasirox	Nutrition and Blood	No data available
Exjade 250mg dispersible tablets 0901030K0BBABAB	Exjade	Deferasirox	Nutrition and Blood	No data available
Exjade 500mg dispersible tablets 0901030K0BBACAC	Exjade	Deferasirox	Nutrition and Blood	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.